We are live on ! Find out more
ESPR

Esperion Therapeutics
ESPR

Delisted

ESPR was delisted on the 10th of July, 2026.

156 hedge funds and large institutions have $1.21B invested in Esperion Therapeutics in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 67 increasing their positions, 45 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 45

15.22% more ownership

Funds ownership: 100%115.22% (+15%)

17% less funds holding

Funds holding: 187156 (-31)

37% less capital invested

Capital invested by funds: $1.91B → $1.21B (-$704M)

43% less funds holding in top 10

Funds holding in top 10: 74 (-3)

58% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 52

76% less call options, than puts

Call options by funds: $25M | Put options by funds: $105M

Holders
156
Holders Change
-31
Holders Change %
-16.58%
% of All Funds
3.57%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.09%
New
22
Increased
67
Reduced
45
Closed
52
Calls
$25M
Puts
$105M
Net Calls
-$79.7M
Net Calls Change
-$33M